Next Wave in Immune Therapeutics

At Johnson & Johnson Innovation, we seek to collaborate with early-stage companies and researchers to generate transformational healthcare solutions that can bring value to patients.

Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, our Johnson & Johnson Innovation team will host on 29-30 September a virtual scientific and partnering event on state-of-the-art developments in immunology, bringing together entrepreneurs, start-ups, researchers, and scientists from across Europe and beyond.

The event will include:
•    a keynote on our latest innovations in immunology
•    a panel discussion with European thought leaders in the field
•    a briefing on the Johnson & Johnson Innovation model for supporting scientists and entrepreneurs
•    one-to-one partnering meetings between the Johnson & Johnson Innovation team and selected companies, researchers or other organizations
 
Companies/Researchers/Organizations that have a presence in EMEA and are interested in talking to the team in 1:1 virtual meetings need to apply by Thursday 10 September EOD CEST by submitting their non-confidential information. Registrations for the actual event will be accepted until the event kick-off on 29 September at 15:00 CEST.

Click here to find out more and register